HYPD
HYPERION DEFI, INC.
Key Financials
Operating Income
$-46721061
↑ 4.1%
EPS (Diluted)
$-9.40
↑ 84.3%
Gross Profit
$510165
↑ 113.2%
Revenue
$813455
↑ 1318.8%
Net Income
$-45314435
↑ 9.0%
Total Assets
$51.8M
↑ 1311.3%
Total Liabilities
$10.7M
↓ 36.1%
Cash & Equivalents
$6.4M
↑ 203.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/1/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| 8-K | 7/1/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| SCHEDULE 13G/A | 7/1/2026 | View on SEC |
| 8-K | 6/5/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HYPD |
| Company Name | HYPERION DEFI, INC. |
| CIK | 1682639 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 833-393-6684 |